Willem‐Jan Metsemakers

Dr. Willem‐Jan Metsemakers

Department of Trauma Surgery, University Hospitals Leuven, 3000 Leuven, Belgium
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Injury
Verified
Journal Article
Open access
Willem‐Jan MetsemakersWillem‐Jan Metsemakers
Willem‐Jan Metsemakers
MMM. Morgenstern
M. Morgenstern
MMM.A. McNally
M.A. McNally
Fintan  MoriartyFintan Moriarty
Fintan Moriarty
IMI. McFadyen
I. McFadyen
MVM.H.J. Verhofstad
M.H.J. Verhofstad
Fracture-related infection (FRI) is a common and serious complication in trauma surgery. Accurately estimating the impact of this complication has been hampered by the lack of a clear definition. The absence of a working definition of FRI renders existing studies difficult to evaluate or compare. In order to address this issue, an expert group comprised of a number of scientific and medical organizations has been convened, with the support of the AO Foundation, in order to develop a consensus definition. The process that led to this proposed definition started with a systematic literature review, which revealed that the majority of randomized controlled trials in fracture care do not use a standardized definition of FRI. In response to this conclusion, an international survey on the need for and key components of a definition of FRI was distributed amongst all registered AOTrauma users. Approximately 90% of the more than 2000 surgeons who responded suggested that a definition of FRI is required. As a final step, a consensus meeting was held with an expert panel. The outcome of this process led to a consensus definition of FRI. Two levels of certainty around diagnostic features were defined. Criteria could be confirmatory (infection definitely present) or suggestive. Four confirmatory criteria were defined: Fistula, sinus or wound breakdown; Purulent drainage from the wound or presence of pus during surgery; Phenotypically indistinguishable pathogens identified by culture from at least two separate deep tissue/implant specimens; Presence of microorganisms in deep tissue taken during an operative intervention, as confirmed by histopathological examination. Furthermore, a list of suggestive criteria was defined. These require further investigations in order to look for confirmatory criteria. In the current paper, an overview is provided of the proposed definition and a rationale for each component and decision. The intention of establishing this definition of FRI was to offer clinicians the opportunity to standardize clinical reports and improve the quality of published literature. It is important to note that the proposed definition was not designed to guide treatment of FRI and should be validated by prospective data collection in the future.

1 March 2018 in Injury
Verified
Journal Article
Closed access
Willem‐Jan MetsemakersWillem‐Jan Metsemakers
Willem‐Jan Metsemakers
RKR. Kuehl
R. Kuehl
Fintan  MoriartyFintan Moriarty
Fintan Moriarty
RRRobert Geoff Richards
Robert Geoff Richards
MVM.H.J. Verhofstad
M.H.J. Verhofstad
MMM. Morgenstern
M. Morgenstern

3 March 2022 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
SUSaartje Uyttebroek
Saartje Uyttebroek
BCBaixing Chen
Baixing Chen
JOJolien Onsea
Jolien Onsea
FRFred Ruythooren
Fred Ruythooren
YDYves Debaveye
Yves Debaveye
Willem‐Jan MetsemakersWillem‐Jan Metsemakers
Willem‐Jan Metsemakers

1 January 2020 in Journal of Orthopaedic Trauma
Verified
Journal Article
Open access
GGGeertje A. M. Govaert
Geertje A. M. Govaert
RKRichard Kuehl
Richard Kuehl
BABridget L. Atkins
Bridget L. Atkins
ATAndrej Trampuz
Andrej Trampuz
MMMario Morgenstern
Mario Morgenstern
OGon behalf of the Fracture-Related Infection (FRI) Consensus Group
on behalf of the Fracture-Related Infection (FRI) Consensus Group
Summary: Fracture-related infection (FRI) is a severe complication after bone injury and can pose a serious diagnostic challenge. Overall, there is a limited amount of scientific evidence regarding diagnostic criteria for FRI. For this reason, the AO Foundation and the European Bone and Joint Infection Society proposed a consensus definition for FRI to standardize the diagnostic criteria and improve the quality of patient care and applicability of future studies regarding this condition. The aim of this article was to summarize the available evidence and provide recommendations for the diagnosis of FRI. For this purpose, the FRI consensus definition will be discussed together with a proposal for an update based on the available evidence relating to the diagnostic value of clinical parameters, serum inflammatory markers, imaging modalities, tissue and sonication fluid sampling, molecular biology techniques, and histopathological examination. Second, recommendations on microbiology specimen sampling and laboratory operating procedures relevant to FRI will be provided. Level of Evidence: Diagnostic Level V. See Instructions for Authors for a complete description of levels of evidence.

29 October 2019 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Open access
PDF file
OGOn behalf of the Fracture-Related Infection (FRI) group
On behalf of the Fracture-Related Infection (FRI) group
Willem‐Jan MetsemakersWillem‐Jan Metsemakers
Willem‐Jan Metsemakers
MMMario Morgenstern
Mario Morgenstern
ESEric Senneville
Eric Senneville
OBOlivier Borens
Olivier Borens
WOWilliam T. Obremskey
William T. Obremskey
Fracture-related infection (FRI) remains a challenging complication that creates a heavy burden for orthopaedic trauma patients, their families and treating physicians, as well as for healthcare systems. Standardization of the diagnosis of FRI has been poor, which made the undertaking and comparison of studies difficult. Recently, a consensus definition based on diagnostic criteria for FRI was published. As a well-established diagnosis is the first step in the treatment process of FRI, such a definition should not only improve the quality of published reports but also daily clinical practice. The FRI consensus group recently developed guidelines to standardize treatment pathways and outcome measures. At the center of these recommendations was the implementation of a multidisciplinary team (MDT) approach. If such a team is not available, it is recommended to refer complex cases to specialized centers where a MDT is available and physicians are experienced with the treatment of FRI. This should lead to appropriate use of antimicrobials and standardization of surgical strategies. Furthermore, an MDT could play an important role in host optimization. Overall two main surgical concepts are considered, based on the fact that fracture fixation devices primarily target fracture consolidation and can be removed after healing, in contrast to periprosthetic joint infection were the implant is permanent. The first concept consists of implant retention and the second consists of implant removal (healed fracture) or implant exchange (unhealed fracture). In both cases, deep tissue sampling for microbiological examination is mandatory. Key aspects of the surgical management of FRI are a thorough debridement, irrigation with normal saline, fracture stability, dead space management and adequate soft tissue coverage. The use of local antimicrobials needs to be strongly considered. In case of FRI, empiric broad-spectrum antibiotic therapy should be started after tissue sampling. Thereafter, this needs to be adapted according to culture results as soon as possible. Finally, a minimum follow-up of 12 months after cessation of therapy is recommended. Standardized patient outcome measures purely focusing on FRI are currently not available but the patient-reported outcomes measurement information system (PROMIS) seems to be the preferred tool to assess the patients’ short and long-term outcome. This review summarizes the current general principles which should be considered during the whole treatment process of patients with FRI based on recommendations from the FRI Consensus Group. Level of evidence: Level V.

1 May 2020 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
MDMelissa Depypere
Melissa Depypere
MMM. Morgenstern
M. Morgenstern
RKR. Kuehl
R. Kuehl
ESE. Senneville
E. Senneville
TMT.F. Moriarty
T.F. Moriarty
Willem‐Jan MetsemakersWillem‐Jan Metsemakers
Willem‐Jan Metsemakers